Acadia Pharmaceuticals (ACAD) PT Lowered to $37 at Mizuho Securities

March 12, 2021 6:37 AM EST
Get Alerts ACAD Hot Sheet
Price: $21.15 -0.24%

Rating Summary:
    10 Buy, 13 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 17 | Down: 13 | New: 41
Trade Now! 
Join SI Premium – FREE
Mizuho Securities analyst Vamil Divan lowered the price target on Acadia Pharmaceuticals (NASDAQ: ACAD) to $37.00 (from $55.00) while maintaining a Buy rating.

You May Also Be Interested In

Related Categories

Analyst PT Change